Startup · $4.5m raised
Melbourne, VIC
Every investor coverage indicates participated in a round Neurala Biosciences raised.
| Investor | Rounds | Invested |
|---|---|---|
| Genesis Pre-Seed Fund | Unnamed stage | - |
| Tin Alley Ventures | Unnamed stage | - |
Companies Neurala Biosciences acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Daniel Perkins | CEO | LaunchVic |
| Dr Jerome Sarris | CSO | LaunchVic |
Stories naming Neurala Biosciences. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Profile of Melbourne-based biotech Neurala Biosciences, founded by two researchers turning DMT and harmala compounds into medicines, covering its origins, grant and investor backing totalling $4.5m, and planned first-in-human studies.